Long-Acting Injectable Second-Generation Antipsychotics in Seriously Ill Patients with Schizophrenia: Doses, Plasma Levels, and Treatment Outcomes

Long-Acting Injectable Second-Generation Antipsychotics in Seriously Ill Patients with Schizophrenia: Doses, Plasma Levels, and Treatment Outcomes

This research studies the dose–plasma level (PL) relationship of second-generation antipsychotics, together with the treatment outcomes achieved, in seriously ill people with schizophrenia. An observational, prospective, one-year follow-up study was carried out with patients (N = 68) with severe sch...

Full description

Bibliographic Details
Main Authors: Juan José Fernández-Miranda, Silvia Díaz-Fernández, Francisco Javier Cepeda-Piorno, Francisco López-Muñoz
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Biomedicines
Subjects:
schizophrenia
clinical severity
long-acting injectable antipsychotic
paliperidone
aripiprazole
dose
Online Access:https://www.mdpi.com/2227-9059/12/1/165

Internet

https://www.mdpi.com/2227-9059/12/1/165

Similar Items